Donald E. Ingber

Boston Children's Hospital, Harvard University

Papers

13

Total Citations

1,685

H-Index

11

About

Donald E. Ingber is a visionary leader in biologically inspired engineering, whose work bridges fundamental biology with transformative technology. As the founding director of the Wyss Institute at Harvard University, his research spans organ-on-a-chip systems, cellular tensegrity, and soft robotics. Ingber’s most impactful contributions include the development of vascularized organ chips that can quantitatively predict human pharmacokinetic responses to drugs—a breakthrough that has garnered over 460 citations and promises to revolutionize drug testing and personalized medicine. His pioneering work on robotic fluidic coupling of multiple organ chips (over 400 citations) enables unprecedented simulation of human physiology in vitro. Ingber is also renowned for his tensegrity model of cellular structure, which he extended to the self-assembly of three-dimensional DNA nanostructures (383 citations). Beyond these, he has advanced stem cell differentiation platforms and bioinspired soft robotic actuators. With over 30,000 total citations and numerous awards, including election to the National Academy of Medicine, Ingber’s work exemplifies how understanding nature’s design principles can lead to powerful innovations in medicine, robotics, and materials science.

Research Focus

Key Achievements

11
H-Index
13
Papers
1,685
Total Citations
130
Avg Citations/Paper
🏆 Most Cited Paper
Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips
463 citations · 2020
📈 Most Prolific Year: 2020 (3 Papers)
🤝 Key Collaborators: 86
🏛 Institutions: Boston Children's Hospital, Harvard University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago